CIK 0002036042
- Non-accelerated filer
- Smaller reporting company
- Emerging growth company
Sionna Therapeutics, Inc.
Sign in to watch- Ticker
- SION
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- Phone
- +1 617-819-2020
- Business address
- 21 HICKORY DRIVE, SUITE 500, WALTHAM, MA, 02451
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $21,835,018
- in 1 filing
Net −$21,835,018. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-09-17 | Cloonan Michael President & CEO | Grant or award | +109,025 | 656,368 | ||
| 2026-09-17 | Cloonan Michael President & CEO | Grant or award | +109,025 | 765,393 | ||
| 2026-09-17 | Cloonan Michael President & CEO | Grant or award · Non-Qualified Stock Option (right to buy) | +436,100 | 436,100 | ||
| 2026-09-17 | Cloonan Michael President & CEO | Returned to the company · Non-Qualified Stock Option (right to buy) | −436,100 | 0 | ||
| 2026-01-02 | Cloonan Michael President & CEO | Grant or award · Non-Qualified Stock Option (right to buy) | +436,100 | 436,100 | ||
| 2025-10-21 | Cloonan Michael President & CEO | Option exercise 10b5-1 | +13,324 | $6.11 | $81K | 560,667 |
| 2025-10-21 | Cloonan Michael President & CEO | Sale 10b5-1 | −13,324 | $34.44 | $459K | 547,343 |
| 2025-10-21 | Cloonan Michael President & CEO | Option exercise 10b5-1 | +30,049 | $6.11 | $184K | 577,392 |
| 2025-10-21 | Cloonan Michael President & CEO | Sale 10b5-1 | −30,049 | $35.63 | $1.1M | 547,343 |
| 2025-10-21 | Cloonan Michael President & CEO | Option exercise 10b5-1 | +22,895 | $6.11 | $140K | 570,238 |
| 2025-10-21 | Cloonan Michael President & CEO | Sale 10b5-1 | −22,895 | $36.60 | $838K | 547,343 |
| 2025-10-21 | Cloonan Michael President & CEO | Option exercise 10b5-1 | +33,532 | $6.11 | $205K | 580,875 |
| 2025-10-21 | Cloonan Michael President & CEO | Sale 10b5-1 | −33,532 | $37.31 | $1.3M | 547,343 |
| 2025-10-21 | Cloonan Michael President & CEO | Option exercise · Non-Qualified Stock Option (right to buy) 10b5-1 | −13,324 | 139,618 | ||
| 2025-10-21 | Cloonan Michael President & CEO | Option exercise · Non-Qualified Stock Option (right to buy) 10b5-1 | −30,049 | 109,569 | ||
| 2025-10-21 | Cloonan Michael President & CEO | Option exercise · Non-Qualified Stock Option (right to buy) 10b5-1 | −22,895 | 86,674 | ||
| 2025-10-21 | Cloonan Michael President & CEO | Option exercise · Non-Qualified Stock Option (right to buy) 10b5-1 | −33,532 | 53,142 | ||
| 2025-10-16 | Cloonan Michael President & CEO | Option exercise 10b5-1 | +10,225 | $6.11 | $62K | 557,568 |
| 2025-10-16 | Cloonan Michael President & CEO | Sale 10b5-1 | −10,225 | $31.46 | $322K | 547,343 |
| 2025-10-16 | Cloonan Michael President & CEO | Option exercise 10b5-1 | +200 | $6.11 | $1K | 547,543 |
Page 1 of 3 · 42 trades